FAM
RVNC
Flaharty Asset Management’s Revance Therapeutics, Inc. RVNC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-32,000
| Closed | -$157K | – | 127 |
|
|
2024
Q1 | $157K | Buy |
+32,000
| New | +$157K | 0.02% | 115 |
|
|
2023
Q2 | – | Sell |
-6,952
| Closed | -$224K | – | 117 |
|
|
2023
Q1 | $224K | Sell |
6,952
-6,500
| -48% | -$209K | 0.04% | 104 |
|
|
2022
Q4 | $248K | Buy |
13,452
+1,000
| +8% | +$18.5K | 0.05% | 97 |
|
|
2022
Q3 | $336K | Sell |
12,452
-5,000
| -29% | -$135K | 0.07% | 81 |
|
|
2022
Q2 | $241K | Buy |
17,452
+2,000
| +13% | +$27.6K | 0.05% | 99 |
|
|
2022
Q1 | $301K | Hold |
15,452
| – | – | 0.06% | 89 |
|
|
2021
Q4 | $252K | Buy |
+15,452
| New | +$252K | 0.05% | 110 |
|